Analyst Ranking
Bottom 39%
#3208 out of 5150 analysts
Average Return
+0.01%
Win Rate
52%14 out of 27
Risk vs Reward
Poor
Good

Michael Ryskin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Singular Genomics Systems IncOMIC
+79.62%$103.20$21.03
2022-08-09 -
2023-08-09
Sell
Absci CorpABSI
+75.41%$12.89$3.17
2021-11-09 -
2022-11-09
Sell
Guardant Health IncGH
+51.78%$31.15$47.28
2024-07-17 -
2025-07-17
Strong Buy
Tempus Ai IncTEM
+48.55%$34.50$51.25
2024-07-08 -
2024-10-02
Strong Buy
Avantor IncAVTR
+34.42%$20.57$27.65
2023-07-30 -
2024-07-30
Strong Buy

Michael Ryskin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Revvity IncRVTY
1Strong Buy$99.00-1.48%Maintains
3 months ago
Tempus Ai IncTEM
6Hold$70.00-0.86%Maintains
6 months ago
Idexx Laboratories IncIDXX
3Hold$475.00-32.55%Maintains
8 months ago
Maravai Lifesciences Holdings IncMRVI
3Strong Buy$8.00+122.22%Maintains
9 months ago
Align Technology IncALGN
6Sell$206.00N/AMaintains
a year ago
Guardant Health IncGH
1Strong Buy$40.00N/AMaintains
a year ago
Alight IncALIT
1Strong Buy$9.50N/AMaintains
a year ago
Exscientia PLCEXAI
2Hold$9.00N/ADowngrades
2 years ago
Certara IncCERT
2Strong Buy$24.00N/AMaintains
2 years ago
Avantor IncAVTR
2Strong Buy$24.00N/AMaintains
2 years ago
Abcam PLCABCM
2Strong Buy$25.00N/AUpgrades
2 years ago
Zoetis IncZTS
6Strong Buy$180.00N/AMaintains
3 years ago
Singular Genomics Systems IncOMIC
3Sell$90.00N/ADowngrades
3 years ago
Recursion Pharmaceuticals IncRXRX
1HoldN/AN/ADowngrades
4 years ago
Schrodinger IncSDGR
2Hold$52.00N/ADowngrades
4 years ago
Absci CorpABSI
2Sell$10.00N/ADowngrades
4 years ago
Smiledirectclub IncSDCCQ
1Sell$7.00N/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.